HEXA
Beta-hexosaminidase subunit alpha
Also known as: HEXA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06865
- Gene
- HEXA
- Ensembl
- ENSG00000213614
- Chromosome
- 15
- Canonical length
- 529 aa
- Protein class
- Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>P06865|HEXA
1 MTSSRLWFSL LLAAAFAGRA TALWPWPQNF QTSDQRYVLY PNNFQFQYDV SSAAQPGCSV
61 LDEAFQRYRD LLFGSGSWPR PYLTGKRHTL EKNVLVVSVV TPGCNQLPTL ESVENYTLTI
121 NDDQCLLLSE TVWGALRGLE TFSQLVWKSA EGTFFINKTE IEDFPRFPHR GLLLDTSRHY
181 LPLSSILDTL DVMAYNKLNV FHWHLVDDPS FPYESFTFPE LMRKGSYNPV THIYTAQDVK
241 EVIEYARLRG IRVLAEFDTP GHTLSWGPGI PGLLTPCYSG SEPSGTFGPV NPSLNNTYEF
301 MSTFFLEVSS VFPDFYLHLG GDEVDFTCWK SNPEIQDFMR KKGFGEDFKQ LESFYIQTLL
361 DIVSSYGKGY VVWQEVFDNK VKIQPDTIIQ VWREDIPVNY MKELELVTKA GFRALLSAPW
421 YLNRISYGPD WKDFYIVEPL AFEGTPEQKA LVIGGEACMW GEYVDNTNLV PRLWPRAGAV
481 AERLWSNKLT SDLTFAYERL SHFRCELLRR GVQAQPLNVG FCEQEFEQTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HEXA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 145 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 145 nTPM
- bone marrow: 96 nTPM
- placenta: 90 nTPM
- kidney: 78 nTPM
- lung: 75 nTPM
- choroid plexus: 73 nTPM
Single-cell type
- hofbauer cells: 105 nCPM
- microglia: 105 nCPM
- decidual stromal cells: 83 nCPM
- choroid plexus epithelial cells: 79 nCPM
- syncytiotrophoblasts: 74 nCPM
- epididymal principal cells: 66 nCPM
Immune cell
- myeloid DC: 92 nTPM
- classical monocyte: 78 nTPM
- total PBMC: 58 nTPM
- eosinophil: 55 nTPM
- NK-cell: 44 nTPM
- gdT-cell: 39 nTPM
Brain region
- white matter: 41 nTPM
- choroid plexus: 41 nTPM
- pons: 29 nTPM
- medulla oblongata: 29 nTPM
- thalamus: 28 nTPM
- spinal cord: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HEXA.
Disease | AllUniProt
Conditions HEXA is implicated in, by any mechanism.
- GM2-gangliosidosis 1 (GM2G1) MIM:272800
Disease | GeneticClinVar
330 pathogenic / likely-pathogenic of 1,349 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Tay-Sachs disease
- Inborn genetic diseases
- HEXA-related disorder
- Tay-Sachs disease, B1 variant
- Familial cancer of breast
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.41
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult walking behavior
- carbohydrate metabolic process
- cell morphogenesis involved in neuron differentiation
- dermatan sulfate proteoglycan catabolic process
- ganglioside catabolic process
- glycosaminoglycan biosynthetic process
- glycosaminoglycan metabolic process
- hyaluronan catabolic process
- lipid storage
- lysosome organization
- myelination
- N-glycan processing
- neuromuscular process controlling balance
- neuromuscular process controlling posture
- sensory perception of sound
- skeletal system development
Molecular functions
- acetylglucosaminyltransferase activity
- beta-N-acetylhexosaminidase activity
- protein heterodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HEXA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HEXA as an antibody target. Whether an autoantibody or antibody against HEXA could matter depends on whether native HEXA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HEXA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HEXA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...